Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Hadassah Medical Organization
Sponsor:
Information provided by (Responsible Party):
Kerem Eithan, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00889434
First received: April 20, 2009
Last updated: November 11, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)